| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009761 Superficial zone protein-binding molecules and uses thereof |
| 01/24/2002 | US20020009743 That proliferate in an in vitro culture, obtained by differentiating primate pluripotent stem (pPS) cells, where certain proportion of cells are committed to form neuronal cells, glial cells, or both; screening compounds |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009738 Diagnostic methods based on detecting a breast tumor protein, or mRNA encoding such protein, in a sample; oligonucleotide hybridization and/or amplification to simultaneously detect two or more tissue-specific polynucleotides in a sample |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009713 Detecting modulators of brain cell propagation; incubate neurons with modulator, measure amount of proteins or nucleotide sequences associated with preferential neurons, adjustment in amount of protein present indicates modulator |
| 01/24/2002 | US20020009712 Expression vector for use in the evaluation of gene expression in preferential cells; for monitoring tumor cell migration |
| 01/24/2002 | US20020009708 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/24/2002 | US20020009477 Polyesterether copolymer; biodegradation; biocopatibility; porous membranes |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009448 Immunology therapy |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009442 Diagnosis, therapy Aids |
| 01/24/2002 | US20020009440 Method for separating cells using immunorosettes |
| 01/24/2002 | US20020009439 Central nervous system disorders therapy; genetic engineered culture; Alzheimer's disease |
| 01/24/2002 | US20020009435 Polypeptides having haloperoxidase activity |
| 01/24/2002 | US20020009431 Method for transplanting cells into the brain and therapeutic uses therefor |
| 01/24/2002 | US20020009417 Nucleosome-based anti-tumor compositions |
| 01/24/2002 | DE10126344A1 Apoptose-induzierende DNA-Sequenzen Apoptosis-inducing DNA sequences |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/24/2002 | DE10033245A1 Verwendungen des Hitzeschockproteins gp96 Uses of the heat shock protein gp96 |
| 01/24/2002 | DE10031851A1 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | CA2697031A1 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2418155A1 Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416179A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | CA2415726A1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/24/2002 | CA2415481A1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | CA2415347A1 Adenovirus vectors comprising introns |
| 01/24/2002 | CA2415232A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | CA2415202A1 Extracellular matrix protein |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/24/2002 | CA2377666A1 Stem cell reinforcing material |
| 01/23/2002 | EP1174509A1 Novel cytidine deaminase |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174441A2 Antibodies and fv fragment recognizing antigen ior c2 |
| 01/23/2002 | EP1174156A2 Ported tissue implant systems and methods of using same |
| 01/23/2002 | EP1173597A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors |
| 01/23/2002 | EP1173596A2 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173589A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/23/2002 | EP1173588A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173585A1 Epoxide hydrolases of aspergillus origin |
| 01/23/2002 | EP1173584A2 Methods for producing plants with elevated oleic acid content |
| 01/23/2002 | EP1173582A1 Herbicide resistant plants |
| 01/23/2002 | EP1173581A1 Herbicide resistant plants |
| 01/23/2002 | EP1173580A1 Herbicide resistant plants |
| 01/23/2002 | EP1173579A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173554A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/23/2002 | EP1173553A2 Transgenic plant resistant to mycotoxins and methods |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173550A1 Method for diminishing specific immune reactions |
| 01/23/2002 | EP1173549A2 Use of cytokines and mitogens to inhibit pathological immune responses |
| 01/23/2002 | EP1173548A2 Materials and methods relating to neuronal development |
| 01/23/2002 | EP1173543A1 A method for altering the metabolism of a plant |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1017789A4 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 01/23/2002 | EP0755258B1 Methods of treating disease using sertoli cells and allografts or xenografts |
| 01/23/2002 | EP0696205B1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332800A Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332796A Method for separating viral particles |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332375A Method for differentiation and enrichment of cell specific target structure |